These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1382 related items for PubMed ID: 9391691

  • 21. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeous M.
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [Abstract] [Full Text] [Related]

  • 22. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [Abstract] [Full Text] [Related]

  • 23. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S, Ricard P.
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [Abstract] [Full Text] [Related]

  • 24. Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias.
    Haas NA, Fox S, Skinner JR.
    Cardiol Young; 2005 Aug; 15(4):427-30. PubMed ID: 16014194
    [Abstract] [Full Text] [Related]

  • 25. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS.
    J Manag Care Pharm; 2009 Aug 20; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [Abstract] [Full Text] [Related]

  • 27. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
    Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.
    Pharm World Sci; 2004 Apr 20; 26(2):66-78. PubMed ID: 15085940
    [Abstract] [Full Text] [Related]

  • 28. [Clinical course and treatment of ectopic atrial tachycardia in 144 children].
    Ge H, Li X, Zhang Y, Liu H, Jiang H.
    Zhonghua Er Ke Za Zhi; 2015 Mar 20; 53(3):214-9. PubMed ID: 26165020
    [Abstract] [Full Text] [Related]

  • 29. Treatment of atrial ectopic tachycardia in infants < 6 months old.
    Bauersfeld U, Gow RM, Hamilton RM, Izukawa T.
    Am Heart J; 1995 Jun 20; 129(6):1145-8. PubMed ID: 7754946
    [Abstract] [Full Text] [Related]

  • 30. Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia.
    Kovacikova L, Hakacova N, Dobos D, Skrak P, Zahorec M.
    Ann Thorac Surg; 2009 Aug 20; 88(2):616-22. PubMed ID: 19632422
    [Abstract] [Full Text] [Related]

  • 31. Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
    Yu WC, Chen SA, Lee SH, Tai CT, Feng AN, Kuo BI, Ding YA, Chang MS.
    Circulation; 1998 Jun 16; 97(23):2331-7. PubMed ID: 9639377
    [Abstract] [Full Text] [Related]

  • 32. [Current treatment of supraventricular tachycardia: drug therapy].
    Manz M, Lüderitz B.
    Z Gesamte Inn Med; 1993 Sep 16; 48(9):430-8. PubMed ID: 8212748
    [Abstract] [Full Text] [Related]

  • 33. [Supraventricular tachycardia in infants, children and adolescents: diagnosis, drug and interventional therapy].
    Paul T, Bertram H, Kriebel T, Windhagen-Mahnert B, Tebbenjohanns J, Hausdorf G.
    Z Kardiol; 2000 Jun 16; 89(6):546-58. PubMed ID: 10929440
    [Abstract] [Full Text] [Related]

  • 34. Safety issues in the treatment of paediatric supraventricular tachycardias.
    Pfammatter JP, Bauersfeld U.
    Drug Saf; 1998 May 16; 18(5):345-56. PubMed ID: 9589846
    [Abstract] [Full Text] [Related]

  • 35. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S.
    Am Heart J; 2001 Feb 16; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [Abstract] [Full Text] [Related]

  • 36. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease.
    Przybylski R, Eberly LM, Alexander ME, Bezzerides VJ, DeWitt ES, Dionne A, Mah DY, Triedman JK, Walsh EP, O'Leary ET.
    J Cardiovasc Electrophysiol; 2023 Dec 16; 34(12):2545-2551. PubMed ID: 37846208
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.
    Miller MR, McNamara RL, Segal JB, Kim N, Robinson KA, Goodman SN, Powe NR, Bass EB.
    J Fam Pract; 2000 Nov 16; 49(11):1033-46. PubMed ID: 11093570
    [Abstract] [Full Text] [Related]

  • 38. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD.
    Congenit Heart Dis; 2014 Nov 16; 9(3):221-7. PubMed ID: 23947935
    [Abstract] [Full Text] [Related]

  • 39. Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
    Dilber E, Mutlu M, Dilber B, Aslan Y, Gedik Y, Celiker A.
    Pediatr Emerg Care; 2010 Feb 16; 26(2):82-4. PubMed ID: 20093999
    [Abstract] [Full Text] [Related]

  • 40. Drug treatment of atrial fibrillation in the managed care era.
    Waldo AL, Prystowsky EN.
    Am J Cardiol; 1998 Mar 12; 81(5A):23C-29C. PubMed ID: 9525569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 70.